Ascendis Pharma A/S

NasdaqGS:ASND

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Denmark

Market Cap

USD 11.58 B

Share Price

USD 191.49

Avg Daily Volume

442,653

Change (1 day)

0.60%

Change (1 year)

52.00%

Change (YTD)

39.09%

Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -234.17 M

Ascendis Pharma A/S Operating Cash Flow is USD -234.17 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -48.58% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -455.41 M, a -15.40% change year over year.
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -538.30 M, a 0.70% change year over year.
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -534.57 M, a 58.42% change year over year.
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -337.44 M.